The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge greenlighted the sale of the remnants of the firm, including its wealth ...

The lawsuit alleged that a sale to Regeneron would violate privacy laws in the individual states. What happens to user's data in the sale?

Maine and 27 other states are suing 23andMe to stop the bankrupt DNA-test firm from selling customers’ genetic data.

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Last week, over two dozen states filed a lawsuit, claiming 23andMe did not have the right to sell the data. By Friday, five stated actively opposed the equity sale.